HEPION PHARMACEUTICALS, INC. Accumulated Other Comprehensive Income
HEPION PHARMACEUTICALS, INC. (HEPA) had Accumulated Other Comprehensive Income of $8.35 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Accumulated Other Comprehensive Income (Loss), Net of Tax
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $8.35K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $8.35K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $8.35K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $8.35K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $8.35K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $8.35K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $8.35K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $8.35K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $8.35K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $8.35K 10-Q · filed 2025-05-19 |
| 2024-12-31 | $8.35K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$53.83K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$53.82K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $9.20K 10-Q · filed 2024-05-21 |
| 2023-12-31 | -$78.78K 10-K · filed 2025-04-08 |
| 2023-09-30 | -$93.93K 10-Q · filed 2023-11-20 |
| 2023-06-30 | -$87.65K 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$70.81K 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$90.17K 10-K · filed 2024-04-16 |
| 2022-09-30 | -$90.33K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$29.97K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $9.15K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $0.00 10-K · filed 2023-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |